XML 32 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements of Cash Flows (unaudited) (USD $)
3 Months Ended
Mar. 31, 2012
Mar. 31, 2011
Cash flows from operating activities:    
Net income $ 1,912,119 $ 324,412
Adjustments to reconcile net income to net cash (used in) provided by operating activities:    
Depreciation and amortization 986,913 920,410
Stock-based compensation expense 320,510 300,275
Deferred income taxes (82,206) (111,293)
Provision for inventory 49,558 711,533
Tax benefit from exercise of stock options (394,076)  
Changes in operating assets and liabilities:    
Accounts receivable 358,471 2,753,690
Inventories (1,769,606) (374,014)
Prepaid expenses, other current and long-term assets (324,152) (580,852)
Long-term deposits and other 8,499 8,499
Accounts payable (476,940) (1,021,405)
Accrued expenses (1,341,407) (966,151)
Deferred revenue (716,667) (668,190)
Income taxes payable (215,156) 2,198
Other long-term liabilities (5,509) (13,165)
Net cash (used in) provided by operating activities (1,689,649) 1,285,947
Cash flows from investing activities:    
Purchase of property and equipment, net (224,059) (76,570)
Net cash used in investing activities (224,059) (76,570)
Cash flows from financing activities:    
Principal payments on debt (400,000) (400,000)
Proceeds from exercise of stock options 114,656 28,945
Tax benefit from exercise of stock options 394,076  
Net cash provided by (used in) financing activities 108,732 (371,055)
Exchange rate impact on cash 30,932 38,556
(Decrease) increase in cash and cash equivalents (1,774,044) 876,878
Cash and cash equivalents at beginning of period 35,777,222 28,201,932
Cash and cash equivalents at end of period $ 34,003,178 $ 29,078,810